Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-03-04 Purchase | 2024-03-06 5:40 pm | 89bio Inc. | ETNB | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 1,350,000 | $15.35 | $20,722,500 | 12,766,948 (Indirect) | View |
2024-02-09 Purchase | 2024-02-13 4:33 pm | PepGen Inc. | PEPG | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 2,557,593 | $10.64 | $27,212,790 | 10,689,545 (Indirect) | View |
2023-12-11 Purchase(A) | 2024-01-17 7:06 pm | Wave Life Sciences Ltd. | WVE | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 1,000,000 | $5 | $5,000,000 | 18,202,009 (Indirect) | View |
2024-01-11 Purchase | 2024-01-12 5:01 pm | Solid Biosciences Inc. | SLDB | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. RA Capital Nexus Fund L.P. Director 10% Owner | 904,160 | $5.53 | $5,000,005 | 4,301,877 (Indirect) | View |
2023-12-11 Purchase | 2023-12-13 4:33 pm | Wave Life Sciences Ltd. | WVE | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 1,000,000 | $5 | $5,000,000 | 19,202,009 (Indirect) | View |
2023-09-21 Purchase | 2023-09-25 4:30 pm | ARS Pharmaceuticals Inc. | SPRY | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director | 2,700,000 | $3.0309 | $8,183,526 | 9,459,678 (Indirect) | View |
2023-08-29 Purchase | 2023-08-31 5:26 pm | ARS Pharmaceuticals Inc. | SPRY | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director | 3,750,000 | $6.2 | $23,250,000 | 6,759,678 (Indirect) | View |
2023-08-18 Purchase | 2023-08-22 5:01 pm | AN2 Therapeutics Inc. | ANTX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. 10% Owner | 1,777,778 | $9 | $16,000,002 | 5,551,295 (Indirect) | View |
2023-07-21 Purchase | 2023-07-25 4:30 pm | Acumen Pharmaceuticals Inc. | ABOS | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 5,161,290 | $7.75 | $39,999,998 | 14,932,063 (Indirect) | View |
2023-07-19 Purchase | 2023-07-21 4:31 pm | Janux Therapeutics Inc. | JANX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 495,008 | $12.46 | $6,167,800 | 9,668,878 (Indirect) | View |
2023-07-05 Purchase | 2023-07-07 4:30 pm | Black Diamond Therapeutics Inc. | BDTX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. Kolchinsky Peter Shah Rajeev M. Director | 935,850 | $5 | $4,679,250 | 3,525,754 (Indirect) | View |
2023-03-28 Purchase | 2023-03-30 5:03 pm | DICE Therapeutics Inc. | DICE | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 509,145 | $29.07 | $14,798,693 | 7,856,612 (Indirect) | View |
2023-03-24 Purchase | 2023-03-30 5:00 pm | 89bio Inc. | ETNB | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 2,461,538 | $16.25 | $39,999,993 | 11,416,948 (Indirect) | View |
2023-03-23 Purchase | 2023-03-27 5:01 pm | DICE Therapeutics Inc. | DICE | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 498,556 | $26.99 | $13,457,372 | 7,347,467 (Indirect) | View |
2023-02-14 Purchase | 2023-02-16 5:04 pm | Mineralys Therapeutics Inc. | MLYS | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director | 1,250,000 | $16 | $20,000,000 | 1,311,247 (Indirect) | View |
2023-01-20 Purchase | 2023-01-24 4:30 pm | Fulcrum Therapeutics Inc. | FULC | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner | 1,923,076 | $13 | $24,999,988 | 11,609,704 (Indirect) | View |
2023-01-06 Purchase | 2023-01-10 5:14 pm | Werewolf Therapeutics Inc. | HOWL | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 1,853,000 | $2.21 | $4,095,130 | 6,144,881 (Indirect) | View |
2023-01-04 Purchase | 2023-01-06 4:39 pm | Fulcrum Therapeutics Inc. | FULC | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner | 180,703 | $7.2761 | $1,314,806 | 9,686,628 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-02-19 Equity Swap | 2024-02-20 8:07 pm | N/A N/A | Icosavax Inc. | ICVX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 5,969,108 | $0 | 0 (Indirect) | View |
2024-02-19 Disposition | 2024-02-20 8:07 pm | N/A N/A | Icosavax Inc. | ICVX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 39,278 | $0 | 0 (Indirect) | View |
2024-02-12 Option Award | 2024-02-14 7:49 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director | 549,755 | $13.5 | 5,400,739 (Indirect) | View |
2024-02-12 Option Award | 2024-02-14 7:49 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director | 1,672,508 | $13.5 | 5,400,739 (Indirect) | View |
2024-02-06 Option Award | 2024-02-08 5:16 pm | N/A N/A | Tyra Biosciences Inc. | TYRA | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 3,180,155 | $13.01 | 11,955,066 (Indirect) | View |
2024-02-06 Option Award | 2024-02-08 5:16 pm | N/A N/A | Tyra Biosciences Inc. | TYRA | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 1,538,457 | $13.01 | 11,955,066 (Indirect) | View |
2023-08-07 Option Award | 2023-08-09 8:00 pm | N/A 2028-08-07 | Wave Life Sciences Ltd. | WVE | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 45,000 | $0 | 45,000 (Indirect) | View |
2023-08-09 Equity Swap | 2023-08-09 5:00 pm | N/A N/A | DICE Therapeutics Inc. | DICE | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Former 10% owners and Director Director | 7,856,612 | $0 | 0 (Indirect) | View |
2023-08-09 Disposition | 2023-08-09 5:00 pm | N/A 2032-06-06 | DICE Therapeutics Inc. | DICE | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Former 10% owners and Director Director | 21,250 | $0 | 0 (Indirect) | View |
2023-06-27 Option Award | 2023-06-28 9:00 pm | N/A 2033-06-26 | ARS Pharmaceuticals Inc. | SPRY | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director | 40,000 | $0 | 40,000 (Indirect) | View |
2023-06-21 Option Award | 2023-06-23 5:09 pm | N/A 2033-06-20 | Werewolf Therapeutics Inc. | HOWL | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 13,200 | $0 | 13,200 (Indirect) | View |
2023-06-14 Option Award | 2023-06-16 5:15 pm | N/A 2033-06-13 | Janux Therapeutics Inc. | JANX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 12,500 | $0 | 12,500 (Indirect) | View |
2023-06-06 Option Award | 2023-06-13 4:21 pm | N/A 2033-06-05 | Acumen Pharmaceuticals Inc. | ABOS | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 25,000 | $0 | 25,000 (Indirect) | View |
2023-06-08 Equity Swap | 2023-06-12 8:23 pm | N/A N/A | Satsuma Pharmaceuticals Inc. | STSA | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Former 10% Owner | 5,914,252 | $0 | 0 (Indirect) | View |
2023-06-08 Disposition | 2023-06-12 8:23 pm | N/A N/A | Satsuma Pharmaceuticals Inc. | STSA | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Former 10% Owner | 60,000 | $0 | 0 (Indirect) | View |
2023-06-07 Option Award | 2023-06-09 4:30 pm | N/A 2033-06-06 | Nkarta Inc. | NKTX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 22,500 | $0 | 22,500 (Indirect) | View |
2023-06-06 Option Award | 2023-06-08 6:00 pm | N/A 2033-06-05 | Aerovate Therapeutics Inc. | AVTE | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 12,500 | $0 | 12,500 (Indirect) | View |
2023-06-06 Option Award | 2023-06-08 5:15 pm | N/A 2033-06-06 | Solid Biosciences Inc. | SLDB | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 9,650 | $0 | 9,650 (Indirect) | View |
2023-06-06 Option Award | 2023-06-08 4:47 pm | N/A 2033-06-05 | Icosavax Inc. | ICVX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 17,000 | $0 | 17,000 (Indirect) | View |
2023-05-26 Option Award | 2023-06-02 6:09 pm | N/A 2033-05-25 | Vor Biopharma Inc. | VOR | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 30,000 | $0 | 30,000 (Indirect) | View |
2023-05-31 Option Award | 2023-06-02 4:31 pm | N/A 2033-05-30 | Tyra Biosciences Inc. | TYRA | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 14,500 | $0 | 14,500 (Indirect) | View |
2023-05-18 Option Award | 2023-05-22 5:22 pm | N/A 2033-05-17 | Eliem Therapeutics Inc. | ELYM | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 10,000 | $0 | 10,000 (Indirect) | View |
2023-02-23 Option Award | 2023-02-27 4:31 pm | N/A N/A | Enliven Therapeutics Inc. | ELVN | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. Former 10% owner | 1,152,460 | $0 | 2,122,465 (Indirect) | View |
2023-02-14 Conversion | 2023-02-16 5:04 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director | 1,928,476 | $0 | 1,311,247 (Indirect) | View |
2023-02-09 Option Award | 2023-02-13 9:13 pm | N/A 2023-02-09 | Mineralys Therapeutics Inc. | MLYS | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 44,000 | $0 | 44,000 (Indirect) | View |
Ownership | 2023-02-09 8:06 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 0 | $0 | 1,928,476 (Indirect) | View |